Transgene silencing of the Hutchinson-Gilford progeria syndrome mutation results in a reversible bone phenotype, whereas resveratrol treatment does not show overall beneficial effects (Q47570124)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Transgene silencing of the Hutchinson-Gilford progeria syndrome mutation results in a reversible bone phenotype, whereas resveratrol treatment does not show overall beneficial effects |
scientific article |
Statements
1 reference
Transgene silencing of the Hutchinson-Gilford progeria syndrome mutation results in a reversible bone phenotype, whereas resveratrol treatment does not show overall beneficial effects (English)
1 reference
Charlotte Strandgren
1 reference
Hasina Abdul Nasser
1 reference
Tomás McKenna
1 reference
Antti Koskela
1 reference
Björn Rozell
1 reference
Maria Eriksson
1 reference
15 April 2015
1 reference
1 reference
29
1 reference
8
1 reference
3193-3205
1 reference